Skip to main content
Login | Suomeksi | På svenska | In English

Browsing by Author "Partinen, Markku"

Sort by: Order: Results:

  • Oulasvirta, Markus; Huutoniemi, Anne; Partinen, Markku (2019)
    The aim of this study was to study prevalence and possible causes of springtime excessive daytime tiredness (EDT) and excessive daytime sleepiness (EDS) in 14-18-year-old students in southern Finland. This was done by having a total of 275 students from the Capital Region of Finland answer structured questionnaires in late autumn and spring. The responses were then analysed. The prevalence of springtime excessive daytime tiredness was 31.6% and that of springtime excessive daytime sleepiness was 12.8%. No significant seasonal variation was noted in either excessive daytime tiredness or excessive daytime sleepiness. Excessive daytime tiredness was significantly more common in girls than in boys (P=0.001). For excessive daytime sleepiness, the difference between sexes was not statistically significant. In multiple logistic regression analysis, intermediate and major sleep deprivation and depression were associated with excessive daytime tiredness. Depression was also associated with excessive daytime sleepiness. From our results we found that tiredness was very common among students, while sleepiness as measured by Epworth sleepiness scale (ESS) was somewhat less common. Girls were significantly more tired than boys, while also being more depressed and stressed. Depression was the biggest risk factor for both sleepiness and tiredness. Sleep deprivation was another significant risk factor for excessive daytime tiredness, but not for sleepiness.
  • Tuomi, Janne; Kuurne-Koivisto, Minna; Partinen, Markku (2016)
    Background: Treatment of chronic insomnia is problematic and alternative methods besides drug therapy are sought out for. The aim of the study was to find out about the effects of Neurosonic-low frequency therapy chair on patients with primary insomnia. Therapy is based on Whole-Body Vibration (WBV). Methods: This pilot study consisted of 16 adults (12 men, 4 women; age range 28 - 65) that suffered from insomnia with an Insomnia Severity Index (ISI) of at least 15. They were randomized into control and intervention groups (8 + 8). Both groups received WBV-treatment for five times. At the start of the study control group had a three week period when they did not receive treatment. Measurements were taken using actigraphy, SCL-90-, WHO-5-, PSQI-, ISI-, EQ-5D-questionnaires and a structured sleep questionnaire based on the Basic Nordic Sleep Questionnaire. Results: After treatment ISI-scores decreased in both groups. After treatment the WHO-5- and EQ-5D VAS-score were also ameliorated. Treatment also lowered SCL-90 scores related to anxiety, obsessive compulsive and somatization symptoms. Conclusions: Our results indicate that WBV-treatment has beneficial effects for people suffering from primary insomnia. WBV-treatment also seems to relieve anxiety. No major adverse effects were detected. WBV-treatment may be useful for example in the treatment of insomnia in situations where pharmacological treatment is insufficient. Further studies should be done to have more information about the usefulness of WBV based therapy in treatment of insomnia.